Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy
This study identified circulating biomarkers that distinguish HCM from other cardiomyopathies with LVH independently from confounders and revealed signaling pathways associated with HCM.
Authors
- Keitaro Akita (ORCID: https://orcid.org/0000-0001-5395-1887)
- Albree Tower‐Rader
- Mathew S. Maurer (ORCID: https://orcid.org/0000-0001-5400-5008)
- Yuichi J. Shimada (ORCID: https://orcid.org/0000-0002-3494-307X)
- Michael A. Fifer (ORCID: https://orcid.org/0000-0002-8363-445X)
Institutions
- Harvard University (US)
- Columbia University Irving Medical Center (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Circulation Heart Failure
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1161/circheartfailure.124.012434
- Citations
- 6
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.41